Jonelle Roback, 55, a retired tax accountant, is one of scores of people with multiple sclerosis (MS) who have suffered debilitating side-effects after being put on to a cheaper new drug while in NHS care.
NHS has been switching patients including Jonelle Roback from Tysabri to the cheaper drug, Tyruko, triggering side-effects.
But when I went to Charing Cross hospital for my infusion last May I was told that they were changing the drug I got to Tyruko.
But when I sent a questionnaire to MS patients about their experience of Tyruko, the 52 replies came from people at 15 different hospitals in England who’ve had similar side-effects.
Here, she tells of her experience after being switched from the drug Tysabri on to its “biosimilar” Tyruko in May last year.
